Security of Pharmaceuticals - Comparing US and EU Standards – Free Download - METTLER TOLEDO
White Paper

Security of Pharmaceuticals - Comparing US and EU Standards – Free Download

White Paper

Understanding the main provisions of legal frameworks for pharmaceutical manufactures

Security of Pharmaceuticals - Comparing US and EU Standards
Security of Pharmaceuticals - Comparing US and EU Standards

The EU's counterfeit protection directive 2011/62 / EU Falsified Medicine Directive (FMD), and the Drug Supply Chain Security Act (DSCSA) have been introduced to ensure greater patient protection. They set the stage for greater pharmaceutical security.

This white paper describes the legal frameworks adopted by the European Union and the United States and the resulting requirements for pharmaceutical companies. It provides practical tips on best practice for coding, production processes, packaging design and data infrastructure.

In addition, the white paper compares the similarities and differences between the FMD and the DSCSA in the following areas:

  • Tamper protection
  • Supply chain documentation
  • Three-pronged security design
  • Data matrix codes, product identifiers & SNI
  • Protection against counterfeiting
  • Management of serialization data
  • Aggregation

Download this informative white paper to learn more

Both the FMD as well the DSCSA require inspection systems with the ability to print serialized 2D codes to verify them and which can handle communication with a centralized database/ERP system. Manufacturers who make their production lines fit both the requirements of US serialization from 27 November 2017 as well as the EU's FMD requirements from 9 February 2019 will be in a position to comply with the pending 2023 DSCSA specifications.

Europe and the United States are considered the world leaders in the safest pharmaceutical markets for patients. However: With 840 million inhabitants, and two-thirds of global pharmaceutical sales, the US and Europe are also a lucrative target for drug crime. New sales channels such as the internet make it increasingly easier for pharmaceutical counterfeiters to market counterfeits directly or to infiltrate the supply chain. These new legal frameworks have been introduced to combat this global threat.

Related White Papers

OEE and Product Inspection – Free Download
This white paper provides a very brief overview of the various components that go into measuring Overall Equipment Effectiveness (OEE). It also discus...
Food Safety Standards and Legislation White Paper
This white paper looks at the most common food safety standards and their latest requirements. It also explains how food manufacturers can meet these...
HACCP Versus HARPC- What is the Difference?
This white paper explains the similarities and differences between HACCP and HARPC.
Validation, Verification and Monitoring For Product Inspection Equipment
This White Paper gives guidance on the essential processes of validation, verification, and routine performance monitoring for in-line product inspect...
 
 
 
 
 
 
 
Thank you for visiting www.mt.com. We have tried to optimize your experience while on the site, but we noticed that you are using an older version of a web browser. We would like to let you know that some features on the site may not be available or may not work as nicely as they would on a newer browser version. If you would like to take full advantage of the site, please update your web browser to help improve your experience while browsing www.mt.com.